Bio-Techne Executive and Leadership Team

James Hippel, the Executive Vice President & Chief Financial Officer at Bio-Techne, directs the company's financial strategy and fiscal operations. Overseeing all financial planning, reporting, and investment activities, Hippel ensures Bio-Techne maintains robust financial health and strategic resource allocation. This executive position involves managing capital, optimizing profitability, and driving financial performance across all business segments. By providing critical financial insights, James Hippel supports Bio-Techne's ongoing investment in research and development, as well as its expansion into new markets. Hippel's financial stewardship is essential for enabling the company's mission to deliver innovative tools for the life sciences and clinical diagnostic communities, securing long-term value for stakeholders.

Steve Crouse, the President, Diagnostics & Spatial Biology Segment at Bio-Techne, leads the strategic development and operational execution for the diagnostics and spatial biology divisions. Crouse drives innovation and market expansion within these critical areas, ensuring Bio-Techne's offerings meet the evolving needs of clinical diagnostic and research communities. This leadership position involves overseeing product portfolios, go-to-market strategies, and fostering advancements in diagnostic technologies and spatial biology solutions. By focusing on these specialized segments, Steve Crouse directly enhances Bio-Techne's impact on disease diagnosis and biological process understanding. Crouse's leadership is instrumental in solidifying Bio-Techne's position as a key provider of advanced tools in these rapidly growing fields.

William Geist, the President, Protein Sciences Segment at Bio-Techne, directs the strategic vision and operational performance of the protein sciences division. Geist spearheads initiatives to advance Bio-Techne's portfolio of innovative tools and bioactive reagents for protein research. This executive role encompasses driving product development, market penetration, and scientific collaboration within the protein sciences domain. By focusing on this core segment, William Geist ensures Bio-Techne continues to empower researchers investigating biological processes and disease mechanisms. Geist's leadership is crucial for maintaining Bio-Techne's reputation for quality and innovation, directly supporting advancements in drug discovery and the development of precise clinical diagnostic methods.

Cheryl Bethune, the Senior Vice President & Chief Human Resources Officer at Bio-Techne, directs all global human capital strategies. Overseeing talent acquisition, development, and retention initiatives, Bethune ensures Bio-Techne attracts and cultivates top-tier scientific and operational talent. This leadership role involves fostering a robust organizational culture that supports innovation and collaboration across all departments. By aligning HR policies with Bio-Techne's mission, Cheryl Bethune drives employee engagement and operational efficiency. The strategic management of human resources directly impacts the company's ability to advance scientific discovery and clinical diagnostics. Bethune's focus remains on building a high-performing workforce essential for sustained growth and market leadership in the life sciences sector.

Gary Latham, the Vice President - Chief Technology Officer at Bio-Techne, architects the company's technological infrastructure and innovation roadmap. Overseeing all aspects of technology development and deployment, Latham ensures Bio-Techne leverages cutting-edge solutions to enhance its product offerings and operational capabilities. This critical role involves guiding the integration of advanced digital tools and platforms that support scientific research and clinical diagnostics. By driving technological advancement, Gary Latham directly contributes to the company's ability to provide innovative tools and bioactive reagents. Latham's strategic vision for technology empowers Bio-Techne to maintain its competitive edge in the rapidly evolving life sciences landscape, facilitating breakthroughs in disease investigation and drug discovery.

Brenda Everson, the Senior Vice President. Chief Human Resources Officer at Bio-Techne, spearheads the strategic direction of human resources operations. Everson's responsibilities encompass the development and implementation of comprehensive HR programs designed to support Bio-Techne's global workforce. This includes talent management, organizational development, and ensuring a compliant and engaging work environment. By focusing on employee well-being and professional growth, Brenda Everson cultivates a culture conducive to scientific innovation and operational excellence. Everson's leadership ensures that Bio-Techne's human capital strategy effectively supports the company's mission to provide advanced tools for research and clinical diagnostics. The effective management of personnel directly underpins Bio-Techne's capacity for sustained growth and market impact.

Laurie Gilman, the Vice President, Finance Operations & Chief of Staff at Bio-Techne, manages critical financial operations and provides strategic support to executive leadership. Gilman oversees the efficiency and effectiveness of financial processes, ensuring seamless execution of fiscal strategies across the organization. This role involves close collaboration with the CFO and other senior leaders to drive operational improvements and strategic initiatives. By streamlining finance operations, Laurie Gilman enhances Bio-Techne's capacity to allocate resources effectively towards innovation and growth. Gilman's dual focus on operational finance and executive support is vital for advancing Bio-Techne's mission in the life sciences and diagnostics sectors, contributing directly to the company's overall success and market position.